INVITAE

Invitae Cancer Screen, Invitae Cardio Screen, and Invitae Genetic Health Screen are comprehensive tests designed to assess individuals for genetic predispositions to cancer, cardiovascular diseases, metabolic issues, and other health conditions. Detecting such risks early can facilitate timely treatment and prevention.

These screenings utilize advanced genetic code reading technology, known as Next-Generation Sequencing (NGS), ensuring information accuracy of over 99%. The panels cover a broad spectrum of genes associated with health risks, encompassing 65 genes linked to cancer, 83 genes related to cardiovascular and heart diseases, and an additional 19 genes associated with metabolic and other health conditions. The inclusion of genes identified by the American College of Medical Genetics and Genomics (ACMG) further enhances the clinical relevance of these tests.